Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ALLERGOLOGISK INDEKLIMA DIAGNOSTIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.4%   Bankruptcy risk   1.5% 2.2% 2.3% 2.5% 1.4% 2.0% 11.7% 10.0%   Credit score (0-100)   78 68 65 62 77 69 3 3   Credit rating   A BBB BBB BBB A A BB BB   Credit limit (kDKK)   13.9 0.1 0.0 0.0 19.7 0.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   758 650 106 142 205 342 0.0 0.0   EBITDA   554 354 -68.8 -35.0 27.5 215 0.0 0.0   EBIT   554 354 -68.8 -35.0 27.5 215 0.0 0.0   Pre-tax profit (PTP)   694.2 68.0 107.1 94.3 357.9 0.0 0.0 0.0   Net earnings   535.1 64.1 84.9 115.4 278.9 -0.3 0.0 0.0   Pre-tax profit without non-rec. items   694 68.0 107 94.3 358 0.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   391 331 221 183 73.0 130 0.0 0.0   Shareholders equity total   2,473 2,484 2,515 2,533 2,755 2,698 2,514 2,514   Interest-bearing liabilities   3.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,645 2,502 2,543 2,597 2,857 2,749 2,514 2,514   Net Debt   -2,094 -1,950 -2,127 -2,192 -2,455 -2,307 -2,514 -2,514     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   758 650 106 142 205 342 0.0 0.0   Gross profit growth   47.6% -14.3% -83.7% 33.9% 44.4% 67.4% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,645 2,502 2,543 2,597 2,857 2,749 2,514 2,514   Balance sheet change%   26.5% -5.4% 1.7% 2.1% 10.0% -3.8% -8.5% 0.0%   Added value   553.9 354.2 -68.8 -35.0 27.5 215.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   126 -60 -110 -38 -110 57 -130 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   73.0% 54.5% -65.0% -24.7% 13.4% 62.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   29.3% 15.6% 4.2% 3.7% 13.2% 10.9% 0.0% 0.0%   ROI %   31.1% 16.2% 4.3% 3.8% 13.6% 11.2% 0.0% 0.0%   ROE %   24.0% 2.6% 3.4% 4.6% 10.5% -0.0% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   93.5% 99.3% 98.9% 97.5% 96.5% 98.1% 100.0% 50.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -378.1% -550.4% 3,092.2% 6,268.2% -8,928.7% -1,071.3% 0.0% 0.0%   Gearing %   0.2% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 8,789.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   13.1 125.4 82.7 37.7 27.5 51.2 0.0 0.0   Current Ratio   13.1 125.4 82.7 37.7 27.5 51.2 0.0 0.0   Cash and cash equivalent   2,098.2 1,953.4 2,126.6 2,192.3 2,455.5 2,306.9 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   309.3 715.2 728.9 659.9 489.3 541.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 215 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 215 0 0   EBIT / employee   0 0 0 0 0 215 0 0   Net earnings / employee   0 0 0 0 0 -0 0 0